Litigation Details for SALIX PHARMACEUTICALS, INC. v. CIPLA USA, INC. (D.N.J. 2024)
✉ Email this page to a colleague
SALIX PHARMACEUTICALS, INC. v. CIPLA USA, INC. (D.N.J. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-11-01 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | Edward S. Kiel |
| Jury Demand | None | Referred To | Ann Marie Donio |
| Patents | 8,193,196 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SALIX PHARMACEUTICALS, INC. v. CIPLA USA, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for SALIX PHARMACEUTICALS, INC. v. CIPLA USA, INC. (D.N.J. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-11-01 | 1 | Supplement AO 120 Form | HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 8,193,196 …following G Trademarks or G Patents. ( G the patent action involves 35 U.S.C. ยง 292.): DOCKET…Health Ireland Ltd. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
